Annals of the Rheumatic Diseases, 0003-4967
Journal
Publications
- Published
Are there specific genetic risk factors for the different forms of ANCA-associated vasculitis?
Lorraine Harper, 1 Apr 2011, In: Annals of the Rheumatic Diseases. 70, 4, p. 707-U197Research output: Contribution to journal › Article
- E-pub ahead of print
- Published
Systemic juvenile idiopathic arthritis presenting in a young child with long term disability as an adolescent
Janet McDonagh, 1 Dec 2004, In: Annals of the Rheumatic Diseases. 63, 12, p. 1544-8 5 p.Research output: Contribution to journal › Article
- Published
The association of the PTPN22 620W polymorphism with Behcet's disease
Phil Murray & Graham Wallace, 1 Nov 2007, In: Annals of the Rheumatic Diseases. 66, p. 1531-1533 3 p.Research output: Contribution to journal › Article
- Published
The characterisation and determinants of quality of life in ANCA associated vasculitis
Lorraine Harper, Mark Little, Jan 2014, In: Annals of the Rheumatic Diseases. 73, 1, p. 207-11 5 p.Research output: Contribution to journal › Article › peer-review
- Published
The autoimmune-associated genetic variant PTPN22 R620W enhances neutrophil activation and function in patients with rheumatoid arthritis and healthy individuals
Rachel Bayley, Helen McGettrick, Jacqueline Smith, Christopher Buckley & Stephen Young, 2015, In: Annals of the Rheumatic Diseases. 74, 8, p. 1588-95Research output: Contribution to journal › Article › peer-review
- Published
Non-Hodgkin's lymphoma in systemic lupus erythematosus
Caroline Gordon, 1 Oct 2005, In: Annals of the Rheumatic Diseases. 64, p. 1507-09 3 p.Research output: Contribution to journal › Article
- Published
Lymphoma risk in systemic lupus: effects of disease activity versus treatment
Caroline Gordon & 17 others, , 8 Jan 2013, In: Annals of the Rheumatic Diseases.Research output: Contribution to journal › Article › peer-review
- Published
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs
& 6 others, , 1 Dec 2010, In: Annals of the Rheumatic Diseases. 69, 12, p. 2074-2082 9 p.Research output: Contribution to journal › Review article
- Published
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
& 13 others, , Nov 2012, In: Annals of the Rheumatic Diseases. 71, 11, p. 1771-82 12 p.Research output: Contribution to journal › Article › peer-review
- Published
Phase I/II trial of autologous cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
Paul Bacon, 1 Jun 2001, In: Annals of the Rheumatic Diseases. 60, 6, p. 577-584 8 p.Research output: Contribution to journal › Article
- Published
A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells
Andrew Filer, Christopher Buckley, 1 Oct 2011, In: Annals of the Rheumatic Diseases. 70, 10, p. 1857-1865 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis
Lorraine Yeo, Dagmar Scheel-Toellner, 1 Jan 2012, In: Annals of the Rheumatic Diseases. 71, 1, p. 108-113 6 p.Research output: Contribution to journal › Article
- Published
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Caroline Gordon & 20 others, , 16 May 2014, In: Annals of the Rheumatic Diseases.Research output: Contribution to journal › Article › peer-review
- Published
Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment
Christopher Buckley, Jun 2014, In: Annals of the Rheumatic Diseases. 73, 6, p. 1202-1210 9 p.Research output: Contribution to journal › Article › peer-review
- Published
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Christopher Buckley, 17 Mar 2017, In: Annals of the Rheumatic Diseases.Research output: Contribution to journal › Article › peer-review
- Accepted/In press
Disruptive Innovation in Rheumatology; New Networks of Global Public-Private Partnerships are Needed to Take Advantage of Scientific Progress
Christopher Buckley, 26 Feb 2020, (Accepted/In press) In: Annals of the Rheumatic Diseases. 79, 5Research output: Contribution to journal › Article › peer-review
- Published
- Published
- E-pub ahead of print
Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis
Adam Croft, Christopher Buckley, 30 Jul 2018, In: Annals of the Rheumatic Diseases.Research output: Contribution to journal › Article › peer-review